Abstract:Background: Airflow obstruction is a hallmark of disease severity and prognosis in bronchiectasis. The relationship between lung microbiota, airway inflammation, and outcomes in bronchiectasis with fixed airflow obstruction (FAO) remains unclear. This study explores these interactions in bronchiectasis patients, with and without FAO, and compares them to those diagnosed with chronic obstructive pulmonary disease (COPD). Methods: This prospective observational study in Taiwan enrolled patients with either bronchiectasis or COPD. To analyze the lung microbiome and assess inflammatory markers, bronchoalveolar lavage (BAL) samples were collected for 16S rRNA gene sequencing. The study cohort comprised 181 patients: 86 with COPD, 46 with bronchiectasis, and 49 with bronchiectasis and FAO, as confirmed by spirometry. Results: Patients with bronchiectasis, with or without FAO, had similar microbiome profiles characterized by reduced alpha diversity and a predominance of Proteobacteria, distinctly different from COPD patients who exhibited more Firmicutes, greater diversity, and more commensal taxa. Furthermore, compared to COPD and bronchiectasis without FAO, bronchiectasis with FAO showed more severe disease and a higher risk of exacerbations. A significant correlation was found between the presence of Pseudomonas aeruginosa and increased airway neutrophilic inflammation such as Interleukin [IL]-1β, IL-8, and tumor necrosis factor-alpha [TNF]-α, as well as with higher bronchiectasis severity, which might contribute to an increased risk of exacerbations. Moreover, in bronchiectasis patients with FAO, the ROSE (Radiology, Obstruction, Symptoms, and Exposure) criteria were employed to classify individuals as either ROSE (+) or ROSE (-), based on smoking history. This classification highlighted differences in clinical features, inflammatory profiles, and slight microbiome variations between ROSE (-) and ROSE (+) patients, suggesting diverse endotypes within the bronchiectasis with FAO group. Conclusion: Bronchiectasis patients with FAO may exhibit two distinct endotypes, as defined by ROSE criteria, characterized by greater disease severity and a lung microbiome more similar to bronchiectasis without FAO than to COPD. The significant correlation between Pseudomonas aeruginosa colonization and increased airway neutrophilic inflammation, as well as disease severity, underscores the clinical relevance of microbial patterns. This finding reinforces the potential role of these patterns in the progression and exacerbations of bronchiectasis with FAO.

Correlating Reiff Scores with Clinical, Functional, and Prognostic Factors: Characterizing Non-Cystic Fibrosis Bronchiectasis Severity - Validation from a Nationwide Multicenter Study in Taiwan

Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan

Development and Validation of a Risk Score in Chinese Patients with Chronic Heart Failure

The Derivation and Validation of a Scoring System for Identifying Patients with Bronchiectasis at Risk of Exacerbations

Clinical Characteristics and Validation of Bronchiectasis Severity Score Systems for Post-Tuberculosis Bronchiectasis

Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score

Small-airway Dysfunction among Non-Cystic Bronchiectasis Patients with Different Bronchiectasis Severity Index

Development and Validation of a Comprehensive Multiparameter-based Scoring System to Assess Pulmonary Fibrosis Severity

Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan

Correlation of sputum inflammatory markers with severity and blood inflammatory markers in bronchiectasis

Validation of COPD Population Screener Questionnaire in Chinese Population: A National Multicenter Study

Correlation between Air-trapping and Severity of Dyspnea in Non-Cystic Fibrosis Bronchiectasis

A New Scoring System Combining A Four-Section Honeycomb Lung Percentage on HRCT and Other Comprehensive Multiparameter for Evaluating Pulmonary Fibrosis Severity

Predicting mortality in non-cystic fibrosis bronchiectasis patients using distance-saturation product

The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study

Development of a novel score for the diagnosis of bacterial infection in patients with acute-on-chronic liver failure

Prediction of the mortality of severe community-acquired pneumonia by CT image score

Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis

The Role of Impulse Oscillometry in Evaluating Disease Severity and Predicting the Airway Reversibility in Patients With Bronchiectasis

Lung Field-Based Severity Score (LFSS): a Feasible Tool to Identify COVID-19 Patients at High Risk of Progressing to Critical Disease

Impact of preoperative scores on postoperative process in bronchiectasis surgery